Heterocycle compounds and methods of use thereof
A technology of heterocyclic compounds and compounds, applied to isoindoline compounds, tetrahydro-benzazepine derivatives, tetrahydro-isoquinoline compounds, isoindoline derivatives, and treatment of deacetylase Related diseases, packaging products for the treatment of deacetylase-related diseases, tetrahydro-isoquinoline derivatives, treatment of proliferative diseases, tetrahydro-benzazepine compounds, which can solve instability and are not suitable for anticancer drugs And other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0236] Preparation of Arylbromide Heterocyclic Structural Units
[0237]
[0238] 5-Bromo-2,3-dihydro-1H-isoindoline
[0239]
[0240] To a solution of 5-bromophthalimide (44.2 mmol; 1.0 equiv) in THF (221 mL) was added BF under N2 3 -OEt 2 (265.5 mmol; 6.0 equiv), and the reaction was stirred at 25°C for 30 minutes. Will BH 3 -THF (353.6 mmol; 8.0 equiv) was added to the reaction mixture, which was then heated to 40° C. for 24 hours. The reaction was cooled to room temperature and quenched with 60 mL of MeOH until gas evolution ceased; 400 mL of HCl was added and the reaction was refluxed for 3 hours. The reaction was then cooled to room temperature and the aqueous layer was washed with ethyl acetate. The aqueous layer was then adjusted to pH 14 with 6N NaOH and extracted with ethyl acetate. The combined organic extracts were dried (MgSO 4 ), filtered, and concentrated to give crude 5-bromo-2,3-dihydro-1H-isoindole, which was used in the next step without furth...
Embodiment 39
[0315]
[0316] To the cooled (0°C) (E)-3-{2-[2-(2-methyl-1H-indol-3-yl)-ethyl]-1,2,3,4-tetrahydro- Isoquinolin-7-yl}-methyl acrylate (100 mg, 0.264 mmol) in MeOH (2 mL) was added hydroxylamine (175 uL, 50% H 2 O solution, 2.65 mmol) and NaOMe (290 uL, 25% in MeOH, 1.34 mmol). The mixture was stirred at 0°C for 1.5 hours, neutralized with 1N HCl, some solid appeared and a gummy mass formed. The mixture was dissolved in MeOH and purified by preparative HPLC to afford 15 mg (yield: 15%) of (E)-N-hydroxy-3-{2-[2-(2-methyl-1H-ind Indol-3-yl)-ethyl]-1,2,3,4-tetrahydro-isoquinolin-7-yl}-acrylamide.
[0317] Spectral data of prepared N-substituted 2,3-dihydro-isoindoline compounds:
Embodiment 1
[0318] Example 1: (E)-3-(2-Benzyl-2,3-dihydro-1H-isoindol-5-yl)-N-hydroxy-acrylamide
[0319]
[0320] 1 H NMR (400MHz, CD 3 OD): 7.56(d, J=16Hz, 1H), 7.39(m, 8H), 6.45(d, J=16Hz, 1H), 4.21(s, 4H), 4.18(s, 2H), MS m / z 295.0(M +1) +
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
